{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:24:58Z","timestamp":1789640698027,"version":"4.0.0"},"reference-count":186,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-139831OB-I00"],"award-info":[{"award-number":["PID2022-139831OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00093"],"award-info":[{"award-number":["PI20\/00093"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI\/23\/01269"],"award-info":[{"award-number":["PI\/23\/01269"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CERCA Program"},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","award":["2021 SGR 00452"],"award-info":[{"award-number":["2021 SGR 00452"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The human immunodeficiency virus (HIV) is a retrovirus discovered in 1983 as the causative agent of acquired immunodeficiency syndrome (AIDS). Following several zoonotic spillover events from non-human primates, the virus spread between humans for more than 60 years under the radar. HIV infects and kills CD4 T cells, the cells that coordinate adaptive immune responses. Primoinfection is associated with a flu-like symptomatology and chronic infection is clinically silent, and mostly not diagnosed, contributing to viral spread and leading to fatal long-term outcomes. HIV genome codes for a poor reading-proof reverse transcriptase, which facilitates high sequence variability, particularly in the envelope glycoprotein complex, the sole external viral protein and main target of humoral immune responses. This antigenic variability precludes the development of an efficacious vaccine despite 40 years of research. In contrast, the development of antiretroviral drugs represents a scientific and medical success which saved the lives of millions of infected people and provides today an excellent protection against AIDS, although it does not permit viral eradication. Indeed, HIV can integrate its genome in target cells and generates a pool of latently infected cells which escape eradication by both the natural immune response and treatments. In summary, the efforts to tackle HIV have been suboptimal, and the virus has infected more than 90 million people and caused 44 million deaths worldwide. In the absence of a vaccine, a better deployment of available preventative and therapeutic tools is needed, particularly in geographical areas and communities with the highest incidence of infection.<\/jats:p>","DOI":"10.3390\/ijms262311381","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:46:18Z","timestamp":1764067578000},"page":"11381","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Under the Radar: Immune Evasion, Pathogenesis and Control of HIV Infection"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1569-0126","authenticated-orcid":false,"given":"Ferran","family":"Tarr\u00e9s-Freixas","sequence":"first","affiliation":[{"name":"IrsiCaixa, Ctra del Canyet S\/N., 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3809-042X","authenticated-orcid":false,"given":"Benjamin","family":"Trinit\u00e9","sequence":"additional","affiliation":[{"name":"IrsiCaixa, Ctra del Canyet S\/N., 08916 Badalona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Carrillo","sequence":"additional","affiliation":[{"name":"IrsiCaixa, Ctra del Canyet S\/N., 08916 Badalona, Spain"},{"name":"CIBERINFEC, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-0217","authenticated-orcid":false,"given":"Juli\u00e0","family":"Blanco","sequence":"additional","affiliation":[{"name":"IrsiCaixa, Ctra del Canyet S\/N., 08916 Badalona, Spain"},{"name":"CIBERINFEC, 28029 Madrid, Spain"},{"name":"Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain"},{"name":"Faculty of Medicine, University of Vic-Central University of Vic (UVic-UCC), 08500 Vic, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"ref_1","unstructured":"Centers for Disease Control (CDC) (1981). Pneumocystis Pneumonia\u2014Los Angeles. Morb. Mortal. Wkly. Rep., 30, 250\u2013252."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)","volume":"220","author":"Chermann","year":"1983","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1002\/anie.200901918","article-title":"HIV: A Discovery Opening the Road to Novel Scientific Knowledge and Global Health Improvement (Nobel Lecture)","volume":"48","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_4","unstructured":"UNAIDS (2025). Fact Sheet\u2014Latest Global and Regional Statistics on the Status of the AIDS Epidemic, UNAIDS. Available online: https:\/\/www.unaids.org\/en\/resources\/documents\/2025\/UNAIDS_FactSheet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3201\/eid1112.050394","article-title":"Central African Hunters Exposed to Simian Immunodeficiency Virus","volume":"11","author":"Kalish","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chom.2018.12.002","article-title":"Key Viral Adaptations Preceding the AIDS Pandemic","volume":"25","author":"Sauter","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.virol.2007.06.018","article-title":"Genetic Diversity and Phylogeographic Clustering of SIVcpzPtt in Wild Chimpanzees in Cameroon","volume":"368","author":"Li","year":"2007","journal-title":"Virology"},{"key":"ref_8","unstructured":"Tarres-Freixas, F. (2021). HIV-1 Virus-Like Particles Engineered to Display a High Antigen Density. [Ph.D. Thesis, Autonomous University of Barcelona]. Available online: https:\/\/ddd.uab.cat\/pub\/tesis\/2021\/hdl_10803_674431\/ftf1de1.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.1126531","article-title":"Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1","volume":"313","author":"Keele","year":"2006","journal-title":"Science"},{"key":"ref_10","first-page":"E1343","article-title":"Origin of the HIV-1 Group O Epidemic in Western Lowland Gorillas","volume":"112","author":"Ayouba","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/518935","article-title":"Positive in Vivo Selection of the HIV-1 Envelope Protein Gp120 Occurs at Surface-Exposed Regions","volume":"196","author":"Joos","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/455605a","article-title":"AIDS: Prehistory of HIV-1","volume":"455","author":"Sharp","year":"2008","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature07390","article-title":"Direct Evidence of Extensive Diversity of HIV-1 in Kinshasa by 1960","volume":"455","author":"Worobey","year":"2008","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.1256739","article-title":"HIV Epidemiology. The Early Spread and Epidemic Ignition of HIV-1 in Human Populations","volume":"346","author":"Faria","year":"2014","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1126\/science.288.5472.1789","article-title":"Timing the Ancestor of the HIV-1 Pandemic Strains","volume":"288","author":"Korber","year":"2000","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","article-title":"The Origin and Diversity of the HIV-1 Pandemic","volume":"18","author":"Hemelaar","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(10)70186-9","article-title":"Tracking a Century of Global Expansion and Evolution of HIV to Drive Understanding and to Combat Disease","volume":"11","author":"Tebit","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref_18","first-page":"247","article-title":"HIV\/AIDS Review","volume":"84","author":"Moss","year":"2013","journal-title":"Radiol. Technol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.tim.2019.06.002","article-title":"Molecular Mechanism of HIV-1 Entry","volume":"27","author":"Chen","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-Containing HIV-1 Gp120 Core","volume":"310","author":"Huang","year":"2005","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a Major Co-Receptor for Primary Isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/JLB.2RI0517-200R","article-title":"The Evolution of HIV-1 Entry Phenotypes as a Guide to Changing Target Cells","volume":"103","author":"Joseph","year":"2018","journal-title":"J. Leukoc. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.160.8.3933","article-title":"Dendritic Cells Express Multiple Chemokine Receptors Used as Coreceptors for HIV Entry","volume":"160","author":"Rubbert","year":"1998","journal-title":"J. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.161.6.3195","article-title":"Expression of Chemokine Receptors CXCR4 and CCR5 in HIV-1-Infected and Uninfected Individuals","volume":"161","author":"Ostrowski","year":"1998","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1071\/SH03006","article-title":"The Role of Viral Coreceptors and Enhanced Macrophage Tropism in Human Immunodeficiency Virus Type 1 Disease Progression","volume":"1","author":"Gorry","year":"2004","journal-title":"Sex. Health"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.cell.2024.12.008","article-title":"Passage of the HIV Capsid Cracks the Nuclear Pore","volume":"188","author":"Kreysing","year":"2025","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11809","DOI":"10.1074\/jbc.M116.721647","article-title":"The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-Recruited Pre-Messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes","volume":"291","author":"Rasheedi","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-020922-110929","article-title":"Nuclear Capsid Uncoating and Reverse Transcription of HIV-1","volume":"9","author":"Zila","year":"2022","journal-title":"Annu. Rev. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1128\/JVI.00915-10","article-title":"Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication","volume":"84","author":"Abram","year":"2010","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Domingo, E., and Perales, C. (2019). Viral Quasispecies. PLoS Genet., 15.","DOI":"10.1371\/journal.pgen.1008271"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bmb\/58.1.19","article-title":"Evolutionary and Immunological Implications of Contemporary HIV-1 Variation","volume":"58","author":"Korber","year":"2001","journal-title":"Br. Med. Bull."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.tibs.2014.12.001","article-title":"Host Factors for Retroviral Integration Site Selection","volume":"40","author":"Debyser","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1089\/aid.2018.0118","article-title":"Barriers for HIV Cure: The Latent Reservoir","volume":"34","year":"2018","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gotora, P.T., van der Sluis, R., and Williams, M.E. (2023). HIV-1 Tat Amino Acid Residues That Influence Tat-TAR Binding Affinity: A Scoping Review. BMC Infect. Dis., 23.","DOI":"10.1186\/s12879-023-08123-0"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sherpa, C., and Grice, S.F.J.L. (2020). Structural Fluidity of the Human Immunodeficiency Virus Rev Response Element. Viruses, 12.","DOI":"10.3390\/v12010086"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/JVI.78.4.2082-2087.2004","article-title":"The Human Immunodeficiency Virus Type 1 Ribosomal Frameshifting Site Is an Invariant Sequence Determinant and an Important Target for Antiviral Therapy","volume":"78","author":"Biswas","year":"2004","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/JVI.75.4.1834-1841.2001","article-title":"Maintenance of the Gag\/Gag-Pol Ratio Is Important for Human Immunodeficiency Virus Type 1 RNA Dimerization and Viral Infectivity","volume":"75","author":"Crowe","year":"2001","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"a006924","DOI":"10.1101\/cshperspect.a006924","article-title":"HIV-1 Assembly, Budding, and Maturation","volume":"2","author":"Sundquist","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"19114","DOI":"10.1073\/pnas.0907364106","article-title":"Imaging the Interaction of HIV-1 Genomes and Gag during Assembly of Individual Viral Particles","volume":"106","author":"Jouvenet","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Klein, J.S., and Bjorkman, P.J. (2010). Few and Far between: How HIV May Be Evading Antibody Avidity. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000908"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1462-5822.2010.01542.x","article-title":"Exosomes and Retroviruses: The Chicken or the Egg?","volume":"13","author":"Puertas","year":"2011","journal-title":"Cell Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virusres.2004.08.007","article-title":"Retrovirus Budding","volume":"106","author":"Demirov","year":"2004","journal-title":"Virus Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrmicro3490","article-title":"HIV-1 Assembly, Release and Maturation","volume":"13","author":"Freed","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tim.2015.02.003","article-title":"HIV Cell-to-Cell Transmission: Effects on Pathogenesis and Antiretroviral Therapy","volume":"23","author":"Agosto","year":"2015","journal-title":"Trends Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Perez-Zsolt, D., Cantero-P\u00e9rez, J., Erkizia, I., Benet, S., Pino, M., Serra-Peinado, C., Hern\u00e1ndez-Gallego, A., Castellv\u00ed, J., Tapia, G., and Arnau-Saz, V. (2019). Dendritic Cells from the Cervical Mucosa Capture and Transfer HIV-1 via Siglec-1. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00825"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Perez-Zsolt, D., Martinez-Picado, J., and Izquierdo-Useros, N. (2019). When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses. Viruses, 12.","DOI":"10.3390\/v12010008"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV Preferentially Infects HIV-Specific CD4+ T Cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI22812","article-title":"Dangerous Liaisons at the Virological Synapse","volume":"114","author":"Piguet","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/viro.2002.1764","article-title":"Cell-Surface-Expressed HIV-1 Envelope Induces the Death of CD4 T Cells during GP41-Mediated Hemifusion-like Events","volume":"305","author":"Blanco","year":"2003","journal-title":"Virology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1189\/jlb.0204100","article-title":"R5 HIV Gp120-Mediated Cellular Contacts Induce the Death of Single CCR5-Expressing CD4 T Cells by a Gp41-Dependent Mechanism","volume":"76","author":"Blanco","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"998","DOI":"10.4161\/auto.6880","article-title":"HIV-1 Gp41 Fusogenic Function Triggers Autophagy in Uninfected Cells","volume":"4","author":"Denizot","year":"2008","journal-title":"Autophagy"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature12940","article-title":"Cell Death by Pyroptosis Drives CD4 T-Cell Depletion in HIV-1 Infection","volume":"505","author":"Doitsh","year":"2014","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Bracq, L., Xie, M., Benichou, S., and Bouchet, J. (2018). Mechanisms for Cell-to-Cell Transmission of HIV-1. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00260"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.192.8.1081","article-title":"Apoptosis Control in Syncytia Induced by the HIV Type 1-Envelope Glycoprotein Complex: Role of Mitochondria and Caspases","volume":"192","author":"Ferri","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nature11398","article-title":"HIV-Infected T Cells Are Migratory Vehicles for Viral Dissemination","volume":"490","author":"Murooka","year":"2012","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Rashid, F., Zaongo, S.D., Iqbal, H., Harypursat, V., Song, F., and Chen, Y. (2024). Interactions between HIV Proteins and Host Restriction Factors: Implications for Potential Therapeutic Intervention in HIV Infection. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1390650"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Kmiec, D., and Kirchhoff, F. (2024). Antiviral Factors and Their Counteraction by HIV-1: Many Uncovered and More to Be Discovered. J. Mol. Cell Biol., 16.","DOI":"10.1093\/jmcb\/mjae005"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(03)00602-0","article-title":"Death by Deamination: A Novel Host Restriction System for HIV-1","volume":"114","author":"Goff","year":"2003","journal-title":"Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e55806","DOI":"10.7554\/eLife.55806","article-title":"HIV-1 Vpr Induces Cell Cycle Arrest and Enhances Viral Gene Expression by Depleting CCDC137","volume":"9","author":"Zhang","year":"2020","journal-title":"eLife"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin Inhibits Retrovirus Release and Is Antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"35060","DOI":"10.1074\/jbc.M109.058305","article-title":"HIV-1 Accessory Protein Vpu Internalizes Cell-Surface BST-2\/Tetherin through Transmembrane Interactions Leading to Lysosomes","volume":"284","author":"Iwabu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-virology-111821-100816","article-title":"Small but Highly Versatile: The Viral Accessory Protein Vpu","volume":"10","author":"Volcic","year":"2023","journal-title":"Annu. Rev. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"aac5137","DOI":"10.1126\/science.aac5137","article-title":"HIV-1 Nef Hijacks Clathrin Coats by Stabilizing AP-1:Arf1 Polygons","volume":"350","author":"Shen","year":"2015","journal-title":"Science"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"12518","DOI":"10.1128\/JVI.01838-15","article-title":"AP-2 Is the Crucial Clathrin Adaptor Protein for CD4 Downmodulation by HIV-1 Nef in Infected Primary CD4+ T Cells","volume":"89","author":"Gondim","year":"2015","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nm0396-338","article-title":"Endocytosis of Major Histocompatibility Complex Class I Molecules Is Induced by the HIV-1 Nef Protein","volume":"2","author":"Schwartz","year":"1996","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.4049\/jimmunol.175.9.6050","article-title":"Nef Is Physically Recruited into the Immunological Synapse and Potentiates T Cell Activation Early after TCR Engagement","volume":"175","author":"Fenard","year":"2005","journal-title":"J. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV Infection","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_68","first-page":"216","article-title":"Immunopathogenesis of HIV infection","volume":"29","author":"Coiras","year":"2011","journal-title":"Enfermedades Infecc. Microbiol. Cl\u00ednica"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0b013e3280117f7f","article-title":"In HIV-1 Pathogenesis the Die Is Cast during Primary Infection","volume":"21","author":"Centlivre","year":"2007","journal-title":"Aids"},{"key":"ref_70","first-page":"311","article-title":"The Natural History of HIV Infection","volume":"8","author":"Sabin","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The Immune Response during Acute HIV-1 Infection: Clues for Vaccine Development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a Striking Systemic Cytokine Cascade Prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Gay, C., Dibben, O., Anderson, J.A., Stacey, A., Mayo, A.J., Norris, P.J., Kuruc, J.D., Salazar-Gonzalez, J.F., Li, H., and Keele, B.F. (2011). Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019617"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Pastor, L., Urrea, V., Carrillo, J., Parker, E., Fuente-Soro, L., Jairoce, C., Mandomando, I., Naniche, D., and Blanco, J. (2018). Dynamics of CD4 and CD8 T-Cell Subsets and Inflammatory Biomarkers during Early and Chronic HIV Infection in Mozambican Adults. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01925"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/aid.2006.22.757","article-title":"Elevations in IL-10, TNF-Alpha, and IFN-Gamma from the Earliest Point of HIV Type 1 Infection","volume":"22","author":"Norris","year":"2006","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/QAD.0b013e3283367836","article-title":"Plasma Cytokine Levels during Acute HIV-1 Infection Predict HIV Disease Progression","volume":"24","author":"Roberts","year":"2010","journal-title":"Aids"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kramer, H.B., Lavender, K.J., Qin, L., Stacey, A.R., Liu, M.K.P., di Gleria, K., Simmons, A., Gasper-Smith, N., Haynes, B.F., and McMichael, A.J. (2010). Elevation of Intact and Proteolytic Fragments of Acute Phase Proteins Constitutes the Earliest Systemic Antiviral Response in HIV-1 Infection. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000893"},{"key":"ref_78","unstructured":"Pastor, L. (2017). Identification of Immune Biomarkersfor Use in Early HIV Detection and Monitoring in Sub-Saharian Africa. [Ph.D. Thesis, University of Barcelona]. Available online: https:\/\/www.tdx.cat\/bitstream\/handle\/10803\/565673\/LPP_PhD_THESIS.pdf?sequence=1&isAllowed=y."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/COH.0b013e3282f2bce7","article-title":"Innate Immune Responses in Primary HIV-1 Infection","volume":"3","author":"Borrow","year":"2008","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ploquin, M.J., Madec, Y., Casrouge, A., Huot, N., Passaes, C., L\u00e9curoux, C., Essat, A., Boufassa, F., Jacquelin, B., and Jochems, S.P. (2016). Elevated Basal Pre-Infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV\/SIV Disease Onset. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005774"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/COH.0b013e32832f00c0","article-title":"HIV-1-Specific Antibody Responses during Acute and Chronic HIV-1 Infection","volume":"4","author":"Tomaras","year":"2009","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-Gp41 Antibodies with Ineffective Control of Initial Viremia","volume":"82","author":"Tomaras","year":"2008","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody Neutralization and Escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1128\/JVI.00239-07","article-title":"Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection","volume":"81","author":"Gray","year":"2007","journal-title":"J. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid Evolution of the Neutralizing Antibody Response to HIV Type 1 Infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm.1949","article-title":"Neutralizing Antibodies Generated during Natural HIV-1 Infection: Good News for an HIV-1 Vaccine?","volume":"15","author":"Stamatatos","year":"2009","journal-title":"Nat. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1128\/JVI.01359-09","article-title":"Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the Gp41 Membrane Proximal External Region","volume":"83","author":"Gray","year":"2009","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/nm.4187","article-title":"Determinants of HIV-1 Broadly Neutralizing Antibody Induction","volume":"22","author":"Rusert","year":"2016","journal-title":"Nat. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1128\/JVI.00110-09","article-title":"Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay Together with an Analytical Selection Algorithm","volume":"83","author":"Simek","year":"2009","journal-title":"J. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","article-title":"Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point","volume":"43","author":"Ndhlovu","year":"2015","journal-title":"Immunity"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 Expression on HIV-Specific T Cells Is Associated with T-Cell Exhaustion and Disease Progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Hoffmann, M., Pantazis, N., Martin, G.E., Hickling, S., Hurst, J., Meyerowitz, J., Willberg, C.B., Robinson, N., Brown, H., and Fisher, M. (2016). Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005661"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1056\/NEJMoa1508952","article-title":"Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand","volume":"374","author":"Robb","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12985-019-1276-8","article-title":"The Forces Driving Clonal Expansion of the HIV-1 Latent Reservoir","volume":"17","author":"Liu","year":"2020","journal-title":"Virol. J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.immunol.24.021605.090650","article-title":"Intestinal and Pulmonary Mucosal T Cells: Local Heroes Fight to Maintain the Status Quo","volume":"24","author":"Puddington","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature03501","article-title":"Massive Infection and Loss of Memory CD4+ T Cells in Multiple Tissues during Acute SIV Infection","volume":"434","author":"Mattapallil","year":"2005","journal-title":"Nature"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4+ T Cell Depletion during All Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial Translocation Is a Cause of Systemic Immune Activation in Chronic HIV Infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat. Med."},{"key":"ref_99","first-page":"10","article-title":"Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers","volume":"93","author":"Llano","year":"2019","journal-title":"J. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Soper, A., Kimura, I., Nagaoka, S., Konno, Y., Yamamoto, K., Koyanagi, Y., and Sato, K. (2018). Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control. Front. Immunol, 8.","DOI":"10.3389\/fimmu.2017.01823"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/01.aids.0000242819.72839.db","article-title":"Comparative Analysis of T-Cell Turnover and Homeostatic Parameters in HIV-Infected Patients with Discordant Immune-Virological Responses to HAART","volume":"20","author":"Marchetti","year":"2006","journal-title":"Aids"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jir060","article-title":"Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy","volume":"203","author":"Hunt","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV Infection, Inflammation, Immunosenescence, and Aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/COH.0000000000000923","article-title":"Neuropathogenesis of Acute HIV: Mechanisms, Biomarkers, and Therapeutic Approaches","volume":"20","author":"Jia","year":"2025","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"108047","DOI":"10.1016\/j.pharmthera.2021.108047","article-title":"HIV-Associated Neurotoxicity and Cognitive Decline: Therapeutic Implications","volume":"234","author":"Wallace","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e156049","DOI":"10.1172\/jci.insight.156049","article-title":"Slow Progression of Pediatric HIV Associates with Early CD8+ T Cell PD-1 Expression and a Stem-like Phenotype","volume":"8","author":"Vieira","year":"2023","journal-title":"JCI Insight"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/QAD.0000000000000049","article-title":"A Systematic Review of Definitions of Extreme Phenotypes of HIV Control and Progression","volume":"28","author":"Gurdasani","year":"2014","journal-title":"Aids"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.14-0554","article-title":"Case Report: Rapid HIV Progression during Acute HIV-1 Subtype C Infection in a Mozambican Patient with Atypical Seroconversion","volume":"92","author":"Velasco","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/QAD.0b013e32833ac65c","article-title":"Seronegative HIV-1 Infection: A Review of the Literature","volume":"24","author":"Spivak","year":"2010","journal-title":"Aids"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1016\/j.vaccine.2017.08.070","article-title":"HLA Based Selection of Epitopes Offers a Potential Window of Opportunity for Vaccine Design against HIV","volume":"35","author":"Sundaramurthi","year":"2017","journal-title":"Vaccine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1128\/JVI.00793-10","article-title":"Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B 2705-Restricted CD8+ T Cells","volume":"84","author":"Payne","year":"2010","journal-title":"J. Virol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/tan.13085","article-title":"Impact of HLA-DRB1 Allele Polymorphisms on Control of HIV Infection in a Peruvian MSM Cohort","volume":"90","author":"Llano","year":"2017","journal-title":"HLA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e01805-17","DOI":"10.1128\/JVI.01805-17","article-title":"Factors Leading to the Loss of Natural Elite Control of HIV-1 Infection","volume":"92","author":"Pernas","year":"2018","journal-title":"J. Virol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/088922204322749567","article-title":"The CCR5 and CXCR4 Coreceptors\u2014Central to Understanding the Transmission and Pathogenesis of Human Immunodeficiency Virus Type 1 Infection","volume":"20","author":"Moore","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Kalidasan, V., and Theva Das, K. (2020). Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure?. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00046"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1089\/088922299309801","article-title":"Effect of Long-Term Infection with Nef-Defective Attenuated HIV Type 1 on CD4+ and CD8+ T Lymphocytes: Increased CD45RO+CD4+ T Lymphocytes and Limited Activation of CD8+ T Lymphocytes","volume":"15","author":"Zaunders","year":"1999","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Lassen, K.G., Lobritz, M.A., Bailey, J.R., Johnston, S., Nguyen, S., Lee, B., Chou, T., Siliciano, R.F., Markowitz, M., and Arts, E.J. (2009). Elite Suppressor-Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000377"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Yanes, S., Pernas, M., Marfil, S., Cabrera-Rodr\u00edguez, R., Ortiz, R., Urrea, V., Rovirosa, C., Est\u00e9vez-Herrera, J., Olivares, I., and Casado, C. (2022). The Characteristics of the HIV-1 Env Glycoprotein Are Linked with Viral Pathogenesis. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.763039"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.02338-17","article-title":"Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers","volume":"9","author":"Casado","year":"2018","journal-title":"mBio"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coviro.2019.05.010","article-title":"Elite Controllers and Lessons Learned for HIV-1 Cure","volume":"38","author":"Pernas","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV Viremia and Antibody Seroconversion in Plasma Donors: Implications for Diagnosis and Staging of Primary HIV Infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/jdv.17139","article-title":"2021 European Guideline on HIV Testing in Genito-Urinary Medicine Settings","volume":"35","author":"Palfreeman","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Witzel, T.C., Eshun-Wilson, I., Jamil, M.S., Tilouche, N., Figueroa, C., Johnson, C.C., Reid, D., Baggaley, R., Siegfried, N., and Burns, F.M. (2020). Comparing the Effects of HIV Self-Testing to Standard HIV Testing for Key Populations: A Systematic Review and Meta-Analysis. BMC Med., 18.","DOI":"10.1186\/s12916-020-01835-z"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Serrano-Villar, S., Wu, K., Hunt, P.W., Lok, J.J., Ron, R., Sainz, T., Moreno, S., Deeks, S.G., and Bosch, R.J. (2022). Predictive Value of CD8+ T Cell and CD4\/CD8 Ratio at Two Years of Successful ART in the Risk of AIDS and Non-AIDS Events. eBioMedicine, 80.","DOI":"10.1016\/j.ebiom.2022.104072"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","article-title":"The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex. A Double-Blind, Placebo-Controlled Trial","volume":"317","author":"Fischl","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/21548331.1994.11442959","article-title":"Combination Antiretroviral Therapy for HIV Infection","volume":"29","author":"Fischl","year":"1994","journal-title":"Hosp. Pract."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.idc.2014.06.001","article-title":"Antiretroviral Therapy: Current Drugs","volume":"28","author":"Pau","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less. AIDS Clinical Trials Group 320 Study Team","volume":"337","author":"Hammer","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_129","unstructured":"Kemnic, T.R., and Gulick, P.G. (2021). HIV Antiretroviral Therapy, StatPearls Publishing."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/cpt.3447","article-title":"Lenacapavir: Playing the Long Game in the New Era of Antiretrovirals","volume":"117","author":"Neverette","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2174\/1389200218666170724112412","article-title":"Current Status of the Pharmacokinetics and Pharmacodynamics of HIV-1 Entry Inhibitors and HIV Therapy","volume":"18","author":"Xu","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2020.17025","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel","volume":"324","author":"Saag","year":"2020","journal-title":"JAMA"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/COH.0000000000000971","article-title":"Targeting HIV Myeloid and Central Nervous System Reservoirs for HIV Cure","volume":"20","author":"Grasberger","year":"2025","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-200009080-00007","article-title":"Immunological Benefits of Antiretroviral Therapy in Very Early Stages of Asymptomatic Chronic HIV-1 Infection","volume":"14","author":"Plana","year":"2000","journal-title":"AIDS"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2018.1917","article-title":"HIV Preexposure Prophylaxis: A Review","volume":"319","author":"Amico","year":"2018","journal-title":"JAMA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMoa2411858","article-title":"Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons","volume":"392","author":"Kelley","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Carrillo, J., Clotet, B., and Blanco, J. (2018). Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02429"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAD.0000000000000066","article-title":"Intensification of a Raltegravir-Based Regimen with Maraviroc in Early HIV-1 Infection","volume":"28","author":"Puertas","year":"2014","journal-title":"AIDS"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev.immunol.18.1.665","article-title":"Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy","volume":"18","author":"Pierson","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e99127","DOI":"10.1172\/jci.insight.99127","article-title":"HIV Infection Results in Clonal Expansions Containing Integrations within Pathogenesis-Related Biological Pathways","volume":"3","author":"Haworth","year":"2018","journal-title":"JCI Insight"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nm0298-208","article-title":"Biphasic Kinetics of Peripheral Blood T Cells after Triple Combination Therapy in HIV-1 Infection: A Composite of Redistribution and Proliferation","volume":"4","author":"Pakker","year":"1998","journal-title":"Nat. Med."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Massanella, M., Ouchi, D., Marfil, S., Llibre, J.M., Puertas, M.C., Buz\u00f3n, M.J., Richman, D.D., Orna, E., Stevenson, M., and Gatell, J.M. (2014). Different Plasma Markers of Inflammation Are Influenced by Immune Recovery and CART Composition or Intensification in Treated HIV Infected Individuals. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0114142"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Negredo, E., Back, D., Blanco, J.-R.R.J.J.R., Blanco, J.-R.R.J.J.R., Erlandson, K.M., Garolera, M., Guaraldi, G., Mallon, P., Molt\u00f3, J., and Serra, J.A. (2017). Aging in HIV-Infected Subjects: A New Scenario and a New View. BioMed Res. Int., 2017.","DOI":"10.1155\/2017\/5897298"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1586\/1744666X.2013.842897","article-title":"Immunodiscordant Responses to HAART-Mechanisms and Consequences","volume":"9","author":"Massanella","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1182\/blood-2010-12-322453","article-title":"Immune Reconstitution under Antiretroviral Therapy: The New Challenge in HIV-1 Infection","volume":"117","author":"Corbeau","year":"2011","journal-title":"Blood"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/QAD.0b013e328337b957","article-title":"CD4 T-Cell Hyperactivation and Susceptibility to Cell Death Determine Poor CD4 T-Cell Recovery during Suppressive HAART","volume":"24","author":"Massanella","year":"2010","journal-title":"AIDS"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2015.03.002","article-title":"Increased Risk of Non-AIDS-Related Events in HIV Subjects with Persistent Low CD4 Counts despite CART in the CoRIS Cohort","volume":"117","author":"Pacheco","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12509","article-title":"Antibody-Virus Co-Evolution in HIV Infection: Paths for HIV Vaccine Development","volume":"275","author":"Bonsignori","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-med-091014-090749","article-title":"Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design","volume":"67","author":"Sadanand","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11684-019-0721-9","article-title":"Broadly Neutralizing Antibodies and Vaccine Design against HIV-1 Infection","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2013.03.018","article-title":"Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization","volume":"153","author":"Klein","year":"2013","journal-title":"Cell"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Breden, F., Lepik, C., Longo, N.S., Montero, M., Lipsky, P.E., and Scott, J.K. (2011). Comparison of Antibody Repertoires Produced by HIV-1 Infection, Other Chronic and Acute Infections, and Systemic Autoimmune Disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016857"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1086\/651144","article-title":"Cross-Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression","volume":"201","author":"Euler","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1297-1389","article-title":"Passive Immunization with a Human Monoclonal Antibody Protects Hu-PBL-SCID Mice against Challenge by Primary Isolates of HIV-1","volume":"3","author":"Gauduin","year":"1997","journal-title":"Nat. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/5568","article-title":"Neutralizing Antibody Directed against the HIV-1 Envelope Glycoprotein Can Completely Block HIV-1\/SIV Chimeric Virus Infections of Macaque Monkeys","volume":"5","author":"Shibata","year":"1999","journal-title":"Nat. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/S0264-410X(02)00068-3","article-title":"Passive Transfer Studies to Elucidate the Role of Antibody-Mediated Protection against HIV-1","volume":"20","author":"Mascola","year":"2002","journal-title":"Vaccine"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","volume":"384","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/COH.0000000000000144","article-title":"Broadly Neutralizing Antibody and the HIV Reservoir in Acute HIV Infection: A Strategy toward HIV Remission?","volume":"10","author":"Ananworanich","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1097\/01.aids.0000237362.26370.f8","article-title":"HIV\/AIDS Preventive Vaccine \u2018Prime-Boost\u2019 Phase III Trial: Foundations and Initial Lessons Learned from Thailand","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.1094620","article-title":"A Sound Rationale Needed for Phase III HIV-1 Vaccine Trials","volume":"303","author":"Burton","year":"2004","journal-title":"Science"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4161\/hv.7.4.14123","article-title":"HIV Vaccine Efficacy Trial: Glimmers of Hope and the Potential Role of Antibody-Dependent Cellular Cytotoxicity","volume":"7","author":"Wren","year":"2011","journal-title":"Hum. Vaccines"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12967-015-0392-5","article-title":"A Human Immune Data-Informed Vaccine Concept Elicits Strong and Broad T-Cell Specificities Associated with HIV-1 Control in Mice and Macaques","volume":"13","author":"Mothe","year":"2015","journal-title":"J. Transl. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent Vaccines for Optimal Coverage of Potential T-Cell Epitopes in Global HIV-1 Variants","volume":"13","author":"Fischer","year":"2007","journal-title":"Nat. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 Vaccines Expand the Breadth and Depth of Cellular Immune Responses in Rhesus Monkeys","volume":"16","author":"Barouch","year":"2010","journal-title":"Nat. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1086\/428405","article-title":"Correlation between Immunologic Responses to a Recombinant Glycoprotein 120 Vaccine and Incidence of HIV-1 Infection in a Phase 3 HIV-1 Preventive Vaccine Trial","volume":"191","author":"Gilbert","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(05)67395-3","article-title":"The End or the Beginning of the Drive to an HIV-Preventive Vaccine: A View from over 20 Years","volume":"366","author":"Gallo","year":"2005","journal-title":"Lancet"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV-1 Vaccine among Injection Drug Users in Bangkok, Thailand","volume":"194","author":"Pitisuttithum","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection","volume":"191","author":"Flynn","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.chom.2020.03.018","article-title":"Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?","volume":"27","author":"Klasse","year":"2020","journal-title":"Cell Host Microbe"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2019.11.035","article-title":"Critical Design Criteria for Engineering a Nanoparticulate HIV-1 Vaccine","volume":"317","author":"Thalhauser","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.1128\/JVI.76.17.8875-8889.2002","article-title":"Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1","volume":"76","author":"Sanders","year":"2002","journal-title":"J. Virol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1073\/pnas.1507793112","article-title":"Design and Structure of Two HIV-1 Clade C SOSIP.664 Trimers That Increase the Arsenal of Native-like Env Immunogens","volume":"112","author":"Julien","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41467-019-10262-5","article-title":"Structure and Immunogenicity of a Stabilized HIV-1 Envelope Trimer Based on a Group-M Consensus Sequence","volume":"10","author":"Sliepen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.xphs.2019.01.033","article-title":"Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 Gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens","volume":"108","author":"Whitaker","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Tarr\u00e9s-Freixas, F., Clotet, B., Carrillo, J., and Blanco, J. (2024). Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention. Vaccines, 12.","DOI":"10.3390\/vaccines12030298"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-023-00648-4","article-title":"An Engineered HIV-1 Gag-Based VLP Displaying High Antigen Density Induces Strong Antibody-Dependent Functional Immune Responses","volume":"8","author":"Urrea","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12977-015-0210-4","article-title":"Presenting Native-like HIV-1 Envelope Trimers on Ferritin Nanoparticles Improves Their Immunogenicity","volume":"12","author":"Sliepen","year":"2015","journal-title":"Retrovirology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/14760584.2019.1640117","article-title":"Novel Prime-Boost Vaccine Strategies against HIV-1","volume":"18","author":"Excler","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-018-0103-6","article-title":"Advancing an HIV Vaccine; Advancing Vaccinology","volume":"19","author":"Burton","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1126\/science.aad9195","article-title":"HIV-1 Broadly Neutralizing Antibody Precursor B Cells Revealed by Germline-Targeting Immunogen","volume":"351","author":"Jardine","year":"2016","journal-title":"Science"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Molinos-Albert, L.M., Clotet, B., Blanco, J., and Carrillo, J. (2017). Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine Target. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01154"},{"key":"ref_184","unstructured":"Joint United Nations Programme on HIV\/AIDS (2024). UNAIDS 2024, Joint United Nations Programme on HIV\/AIDS."},{"key":"ref_185","unstructured":"The World Bank (2025, September 01). Life Expectancy at Birth, Total (Years). Available online: https:\/\/data360.worldbank.org\/en\/indicator\/WB_WDI_SP_DYN_LE00_IN?view=trend&country=USA&ave."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2105\/AJPH.2009.159723","article-title":"Rethinking Gender, Heterosexual Men, and Women\u2019s Vulnerability to HIV\/AIDS","volume":"100","author":"Higgins","year":"2010","journal-title":"Am. J. Public Health"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11381\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:49:18Z","timestamp":1764067758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":186,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311381"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311381","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}